On June 11-13, Fibronostics had the privilege of participating in the THASL 2025 Annual Conference, hosted by the Thai Association for the Study of the Liver. The event brought together leading clinicians, researchers, and innovators dedicated to transforming the future of liver care across the region and beyond.

As an exhibitor, Fibronostics proudly showcased its latest advancements in non-invasive liver diagnostics, including solutions like LIVERFASt and LIVERSTAT, which offer clinicians a fast, accessible, and scalable approach to evaluating liver health through a simple blood test.

The conference was a meaningful opportunity for our team to engage with healthcare professionals across specialties, exchange insights, and explore how early detection and non-invasive diagnostics can support better patient outcomes in MASLD, HBV, HCV, and beyond.

“From meaningful conversations to insightful sessions, we left THASL more inspired and more committed than ever to making liver care proactive, precise, and patient-centered.”

We extend our heartfelt thanks to everyone who visited the Fibronostics booth, shared feedback, asked thoughtful questions, and connected with our team. Your energy and collaboration continue to drive our mission forward.

We look forward to building on these conversations and contributing to the advancement of hepatology across Asia and globally.

Until next time, THASL!